Cervical Cancer: Follow-Up and Referral

What to know

The follow-up and referral focus area includes tools and resources to ensure timely referral for diagnostic testing, treatment, and other appropriate next steps (such as genetic testing) when screening tests are abnormal.

Introduction

This page is part of the Cervical Cancer Screening Change Package.

Change concepts are "general notions that are useful for developing more specific strategies for changing a process."1 Change ideas are evidence-based or practice-based "actionable, specific ideas or strategies."1 Each change idea is linked to tools and resources that can be used or adapted to improve cancer screening.

Note: See a list of acronyms used in this change package.

Change concept: Establish relationships with specialists for diagnostic testing and treatment.

Identify and partner with referral services or specialists who can provide follow-up diagnostic tests and/or cancer screening.

Establish two-way communication with referral services or specialists to find out if patients followed up with referrals.

Change concept: Adopt policies and procedures for patient referral and follow-up for diagnostic testing and treatment.

Develop protocols and workflows, such as reminder systems, to ensure follow-up referrals are made.

Implement best practices for notification of abnormal test results and follow-up instructions to the patient.

Create a tracking system for documenting patient follow-up after an abnormal test result.

Use EHR-based clinical decision management tools to guide follow-up care.

Change concept: Overcome barriers to follow-up and treatment.

Identify sources for low-cost or free transportation services for follow-up care.

Offer same-day and open-access scheduling and services outside of traditional hours.

Use patient navigation to help individuals access follow-up services.

Change concept: Implement follow-up processes for regular screening.

Develop tracking systems to document when patients are due for their next regular screening.